A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5847 Following Oral Administration to Healthy Male Subjects and Female Subjects of Non-childbearing Potential.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Posizolid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 08 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 08 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2010 New trial record